Navigation Links
Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement
Date:5/19/2009

Agreement Underscores Morphotek's Commitment to the Development of Farletuzumab for Ovarian Cancer

Agreement Highlights Lonza's Ability to Offer Specialty Development and Manufacturing Solutions

EXTON, Pa. and BASEL, Switzerland, May 19 /PRNewswire/ -- Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, and Lonza Group Ltd jointly announced today that they have executed a manufacturing services agreement to support the development and manufacturing of a subset of antibodies in Morphotek's therapeutic antibody pipeline. The agreement will reserve capacity for commercial manufacturing of Morphotek's lead compound farletuzumab (also known as MORAb-003), which recently entered Phase III clinical trials for ovarian cancer under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA). The collaboration between both parties already encompasses several other monoclonal antibodies currently in clinical or preclinical development.

"Lonza is an ideal partner and collaborator on this project," said Philip Sass, PhD, Executive Vice President and Chief Operating Officer of Morphotek. "They have a great deal of experience and expertise with large scale expression and purification of commercial antibody products. They have demonstrated their ability to develop high-quality material and documentation with several of our programs and serve as an extension of our development team at Morphotek. Based on our working experience, we are confident that Lonza will meet our production, quality goals and timelines for our antibody programs."

"Lonza is excited to participate in supporting the commercial manufacturing of Morphotek's lead compound, farletuzumab," said Stephan Kutzer, Head of Lonza Biopharmaceuticals. "Lonza looks forward to continuing and expanding the Morphotek relationship for both development and manufacturing services using Lonza's proprietar
'/>"/>

SOURCE Morphotek, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Human Genome Sciences and Morphotek(R), Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology
2. Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma
3. ImClone Systems and Lonza Walkersville to Discuss Paperless QC Micro at PDA Annual Meeting
4. Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics
5. Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
6. Simcere Pharmaceutical Group Appoints Dr. Peng Wang as Chief Scientific Officer
7. Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results
8. Tiens Biotech Group (USA) Reports First Quarter Results
9. Adipose-derived Stem Cells Could Help Traumatic Brain Injury Patients, Says Bio-Matrix Scientific Groups, Entest BioMedical Inc. Researcher
10. CPM Resource Center and The Shams Group Partner To Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems
11. Nanosys Licenses Nanowire Technology to QuantuMDx Group for Next Generation Diagnostic and Sequencing Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") ... today announces that application has been sought for 530,000 new ... admitted to trading on AIM. The new Ordinary Shares are ... Philip Haworth, former Chief Executive Officer of Silence. ...
... WEST LAFAYETTE, Ind. ╨ Engineers have discovered details about ... new applications in manufacturing, diagnostics and other research., ... create features and surface textures in metals, ceramics and other ... biosensors. The lasers pulse at durations of 100 femtoseconds, or ...
... CAMBRIDGE, Mass., Dec. 19, 2011 Access Industries ... a new life sciences venture investment initiative to ... team,s experience in startup creation, technology commercialization and ... and also create de-novo spinoffs around potential high-impact ...
Cached Biology Technology:Silence Therapeutics Additional Listing 2Silence Therapeutics Additional Listing 3Research could improve laser-manufacturing technique 2Access BridgeGap Ventures to Focus on Early-Stage Therapeutic Opportunities 2Access BridgeGap Ventures to Focus on Early-Stage Therapeutic Opportunities 3
(Date:4/15/2014)... of Arts and Sciences (KNAW) has announced the names ... prestigious Heineken Prizes (one million US dollars prize money ... their great merits to science. , This year marks ... to the Austrian-American chemist Erwin Chargaff in 1964. , ... to the following laureates: , Christopher M. ...
(Date:4/15/2014)... soon could be powering the forklifts used in warehouses ... faster refueling times than ever before, courtesy of a ... (HHC). , The goal of the project is to ... at low pressure four to five times faster than ... a competitive advantage over batteries for a big slice ...
(Date:4/14/2014)... to unravel the molecular changes that underlie one of ... When the bacterium Yersinia pestis enters the lungs, it ... fatal if untreated. The way in which Y. ... in a matter of days has largely confounded scientists, ... the presence of a protein called the plasminogen activator ...
Breaking Biology News(10 mins):Five scientists awarded prestigious Heineken Prizes 2Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 2Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 3Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 4Plague alters cell death to kill host 2
... Iceland,s Eyjafjallajoekull volcano have produced a 1600 km-wide ash ... and then south, is clearly visible in stark contrast ... May. The volcano began emitting steam and ash ... month. Renewed activity earlier this week caused some flights ...
... Assistant Professor Carla Finkielstein has been presented with a ... by the American Association for Cancer Research (AACR), is ... researchers and increase the recognition of minorities involved in ... in the Department of Biological Sciences in the College ...
... a leading scientist at the Office of Naval Research, discussed ... and wastewater during National Public Radio,s recent "Science Friday" segment. ... of the microbial fuel cell to power different types of ... program officer for ONR,s Naval Biosciences and Biocentric Technology Program. ...
Cached Biology News:Biologist Carla Finkielstein receives Minority Scholar Award 2ONR scientist generates 'mud power' for NPR radio audience 2
... is the universal bioinformatics software that has ... The unique modular design of BioNumerics allows ... any type of data employed for the ... DNA fingerprints, 2-D protein gels, HPLC, VNTR, ...
Request Info...
Cultrex 3D Culture Matrix Rat Collagen I....
Cultrex 3D Culture Matrix BME....
Biology Products: